REMIX THERAPEUTICS Trademark

Trademark Overview


On Monday, September 25, 2023, a trademark application was filed for REMIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REMIX THERAPEUTICS trademark a serial number of 98195999. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 24, 2024. This trademark is owned by Remix Therapeutics Inc.. The REMIX THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respir...

development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation

General Information


Serial Number98195999
Word MarkREMIX THERAPEUTICS
Filing DateMonday, September 25, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Description of MarkThe mark consists of design of sound waves in shades of blue and green preceding the literal elements appearing in dark green REMIX and THERAPEUTICS with REMIX appearing above THERAPEUTICS.
Goods and ServicesPharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; preparations for detecting mutation in RNA genes for medical purposes
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
NOT AVAILABLETHERAPEUTICS
Goods and Servicesdevelopment of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRemix Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, October 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 11, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 16, 2024ASSIGNED TO EXAMINER
Friday, May 17, 2024NON-FINAL ACTION WRITTEN
Friday, May 17, 2024NON-FINAL ACTION E-MAILED
Friday, May 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 27, 2024NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024NON-FINAL ACTION WRITTEN
Monday, September 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2024FINAL REFUSAL E-MAILED
Thursday, October 3, 2024FINAL REFUSAL WRITTEN
Thursday, October 3, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 21, 2024EXAMINER'S AMENDMENT ENTERED
Monday, October 21, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, October 21, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 21, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED